Hostname: page-component-7b7567c8c-tnzcf Total loading time: 0 Render date: 2026-11-12T18:53:13.278Z Has data issue: false hasContentIssue false

The mucosal response of hamsters to a low-intensity superimposed secondary infection with the hookworm Ancylostoma ceylanicum

Published online by Cambridge University Press:  29 April 2010

L.M.M. Alkazmi
Affiliation:
School of Biology, University of Nottingham, University Park, NottinghamNG7 2RD, UK
J.M. Behnke*
Affiliation:
School of Biology, University of Nottingham, University Park, NottinghamNG7 2RD, UK
*
*Fax: +44(0) 115 951 3251 E-mail: jerzy.behnke@nottingham.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

An experiment was conducted to assess the mucosal response to low-dose superimposed challenge with Ancylostoma ceylanicum. Hamsters were assigned to five treatment groups (1–5 respectively): naïve controls; primary immunizing infection controls; challenge controls; immunized, anthelmintic–treated, challenged group; immunized, superimposed challenge group. Group 4 hamsters were resistant to challenge, whereas most of the challenge inoculum larvae established in Group 5. Villus height and crypt depth measurements were initially markedly divergent between these two groups but over time post-challenge (pc) values for both parameters drew nearer and by day 31 pc they were indistinguishable. The greatest change was experienced by Group 4 which showed increasing inflammation and gut pathology during the challenge infection. Mitotic activity in crypts and mast cell counts in the mucosa were highest in Group 5 on day 10 pc, but there was little to distinguish between Groups 4 and 5 by day 31 pc. Goblet cell, eosinophil and Paneth cell counts were very similar throughout in both groups but, in the case of Paneth cells, they were consistent with a possible role in protective immunity to challenge. Some adult worms survived throughout the period of intense inflammation, emphasizing their tremendous resilience and resistance to mucosal host protective responses.

Information

Type
Research Papers
Copyright
Copyright © Cambridge University Press 2010
Figure 0

Table 1Experimental design.

Figure 1

Table 2Recovery of Ancylostoma ceylanicum on days after challenge infection.

Figure 2

Fig. 1The height of villi (above the abscissa) and the depth of crypts of Lieberkühn (below the abscissa) recorded in the five treatment groups on day 10 and day 31 after the secondary infection (day 73 and day 94 of the experiment). Additional data are provided on day 17 and day 25 pc for Groups 4 and 5, which were exposed to the primary infection and then either had their worms removed, followed by challenge infection (Group 4 filled in squares and bold line graph) or had the challenge infection superimposed on the primary infection (Group 5, open circles and dotted line graph). Animals that remained naïve throughout are designated by open columns (Group 1), those given an uninterrupted primary infection by columns filled with stipples (Group 2), and the challenge control group by hatched columns (Group 3). Statistical analysis was confined to data for day 10 and day 31 pc, incorporating all five groups. For villus height this revealed a highly significant effect of treatment (F4,38 = 207.7, P < 0.001) and a significant interaction between treatment and time (F4,38 = 30.3, P < 0.001). There was also a significant effect of time (F1,38 = 11.0, P < 0.001). Model R2 = 95.3%. For crypt depth, the main effect of treatment gave F4,38 = 120.7 (P < 0.001), main effect of time F1,38 = 29.2 (P < 0.001) and the interaction between treatment and time F4,38 = 26.0 (P < 0.001). Model R2 = 92.9%.

Figure 3

Fig. 2The mean number of mitotic figures recorded in the five treatment groups on day 10 and day 31 after the secondary infection (day 73 and day 94 of the experiment). Additional data are provided on day 17 and day 25 pc for Groups 4 and 5 (abbreviated primary+challenge and superimposed challenge, respectively). Key to symbols used is as in fig. 1. Statistical analysis was confined to data for day 10 and day 31 pc, incorporating all five groups. This revealed a highly significant effect of treatment (F4,38 = 65.9, P < 0.001), a weaker significant effect of time (F1,38 = 11.7, P = 0.002) and a significant interaction between treatment and time (F4,38 = 14.4, P < 0.001). Model R2 = 87.4%.

Figure 4

Fig. 3The mean number of mast cells recorded in the five treatment groups on day 10 and day 31 after the secondary infection (day 73 and day 94 of the experiment). Additional data are provided on day 17 and day 25 pc for Groups 4 and 5. Key to symbols used is as in fig. 1. Statistical analysis was confined to data for days 10 and 31 pc, incorporating all five groups. This revealed a highly significant effect of treatment (F4,40 = 43.0, P < 0.001) and a significant interaction between treatment and time (F4,40 = 9.0, P < 0.001), but no main effect of time (F1,40 = 1.87, P = NS). Model R2 = 80.4%.

Figure 5

Fig. 4The mean number of goblet cells recorded in the five treatment groups on day 10 and day 31 after the secondary infection (day 73 and day 94 of the experiment). Additional data are provided on day 17 and day 25 pc. for Groups 4 and 5. Key to symbols used is as in fig. 1. Statistical analysis was confined to data for days 10 and 31 pc, incorporating all five groups. This revealed significant effects of treatment (F4,39 = 7.3, P < 0.001), time (F1,39 = 8.3, P = 0.006) but no interaction between treatment and time (F4,39 = 1.3, P = NS). Model R2 = 41.3%.

Figure 6

Fig. 5The mean number of eosinophils recorded in the five treatment groups on day 10 and day 31 after the secondary infection (day 73 and day 94 of the experiment). Additional data are provided on day 17 and day 25 pc for Groups 4 and 5, which were exposed to both primary and secondary infections. Key to symbols used is as in fig. 1. Statistical analysis was confined to data for days 10 and 31 pc, incorporating all five groups. This revealed significant effects of treatment (F4,40 = 24.3, P < 0.001), time (F1,40 = 7.3 P = 0.01) and interaction between treatment and time (F4,40 = 3.6, P = 0.014). Model R2 = 69.2%.

Figure 7

Fig. 6The mean number of Paneth cells recorded in the five treatment groups on day 10 and day 31 after the secondary infection (day 73 and day 94 of the experiment). Additional data are provided on day 17 and day 25 pc for Groups 4 and 5, which were exposed to both primary and secondary infections. Key to symbols used is as in fig. 1. Statistical analysis was confined to data for days 10 and 31 pc, incorporating all five groups. This revealed a significant effect of treatment (F4,39 = 5.3, P = 0.02), and no other significant effects. Model R2 = 25.3%.